Recent Updates
Recently added Catalysts

PINPOINT System

Phase 1

Biliary Anatomy | Unknown | Other |Stryker Corporation|Last Updated: Dec 2, 2014

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

CONTROLLEDBiomarker
Total Trials1
Total Enrollment38

FDA Designations

No designations recorded

Clinical trial landscape

PINPOINT System · 1 trial · 1 indication

Early Phase 1 1
NCT02070068A Pilot Dosing and Timing Study to Optimize Imaging When Utilizing Endoscopic Fluorescence Imaging System During Laparoscopic Biliary and Hepatic OperationsBiliary Anatomy
COMPLETED38 Analytics
EARLY_PHASE1COMPLETED
A Pilot Dosing and Timing Study to Optimize Imaging When Utilizing Endoscopic Fluorescence Imaging System During Laparoscopic Biliary and Hepatic Operations
Biliary AnatomyUnlock trial analytics

Study Endpoints

Primary Endpoints

Ease of Identification of Biliary Anatomy as Scored by the Surgeon (1-5 scale)
10 minutes after injection
Unlock Study Endpoints

Study Design & Arms

AllocationNON_RANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeDIAGNOSTIC

Treatment Arms

ArmTypeDescription
Group 1EXPERIMENTALICG administered 10 minutes prior to time of visualization
Group 2EXPERIMENTALICG administered 45 min prior to time of visualization

Interventions

NameTypeDescription
PINPOINT SystemDEVICE -
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: To be eligible for the study, subjects must fulfill all of the following criteria: 1. Subjects who are healthy men or women 18 years of age or older. 2. Subjects who are scheduled for laparoscopic biliary or hepatic operations. 3. Subjects who sign an approved informed consent ...

Countries:United States
Unlock Eligibility Criteria

Frequently asked questions about PINPOINT System

What is the PINPOINT System used for?

The PINPOINT System is an endoscopic fluorescence imaging system used to visualize biliary anatomy during laparoscopic biliary and hepatic operations. It is being studied to optimize imaging in these procedures. The system is developed by Stryker Corporation and is currently in early clinical development.

Who makes the PINPOINT System?

Stryker Corporation (NYSE: SYK) develops the PINPOINT System. The company is conducting clinical research on the imaging system for use in visualizing biliary anatomy during laparoscopic biliary and hepatic operations. The system is currently in early-phase clinical development.

What phase is the PINPOINT System in?

The PINPOINT System is in early Phase 1 clinical development. One early-phase trial has been completed, which was a pilot dosing and timing study to optimize imaging during laparoscopic biliary and hepatic operations. The system is investigational and not yet approved.

What clinical trials is the PINPOINT System in?

The PINPOINT System has one completed clinical trial, NCT02070068, titled "A Pilot Dosing and Timing Study to Optimize Imaging When Utilizing Endoscopic Fluorescence Imaging System During Laparoscopic Biliary and Hepatic Operations." This early Phase 1 study enrolled 38 participants in the United States.

Is the PINPOINT System FDA approved?

The PINPOINT System is not FDA approved. It is an investigational device currently in early Phase 1 clinical development. A single early-phase trial has been completed to study its use in imaging biliary anatomy during laparoscopic biliary and hepatic operations.